These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 12853213)

  • 1. Mutations in BRCA1 and BRCA2 and predisposition to prostate cancer.
    Tischkowitz M; Eeles R;
    Lancet; 2003 Jul; 362(9377):80; author reply 80. PubMed ID: 12853213
    [No Abstract]   [Full Text] [Related]  

  • 2. Male BRCA1 and BRCA2 mutation carriers: a pilot study investigating medical characteristics of patients participating in a prostate cancer prevention clinic.
    Horsburgh S; Matthew A; Bristow R; Trachtenberg J
    Prostate; 2005 Oct; 65(2):124-9. PubMed ID: 15880530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRCA1 and BRCA2 mutations have no major role in predisposition to prostate cancer in Finland.
    Ikonen T; Matikainen MP; Syrjäkoski K; Mononen N; Koivisto PA; Rökman A; Seppälä EH; Kallioniemi OP; Tammela TL; Schleutker J
    J Med Genet; 2003 Aug; 40(8):e98. PubMed ID: 12920090
    [No Abstract]   [Full Text] [Related]  

  • 4. The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel.
    Vazina A; Baniel J; Yaacobi Y; Shtriker A; Engelstein D; Leibovitz I; Zehavi M; Sidi AA; Ramon Y; Tischler T; Livne PM; Friedman E
    Br J Cancer; 2000 Aug; 83(4):463-6. PubMed ID: 10945492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators.
    Gayther SA; de Foy KA; Harrington P; Pharoah P; Dunsmuir WD; Edwards SM; Gillett C; Ardern-Jones A; Dearnaley DP; Easton DF; Ford D; Shearer RJ; Kirby RS; Dowe AL; Kelly J; Stratton MR; Ponder BA; Barnes D; Eeles RA
    Cancer Res; 2000 Aug; 60(16):4513-8. PubMed ID: 10969800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer.
    Hamel N; Kotar K; Foulkes WD
    BMC Med Genet; 2003 Aug; 4():7. PubMed ID: 12911837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Update on genetic predisposition to prostate cancer].
    Cussenot O; Cancel-Tassin G
    Bull Cancer; 2015 Jan; 102(1):53-6. PubMed ID: 25609482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRCA1 and BRCA2 have a limited role in familial prostate cancer.
    Sinclair CS; Berry R; Schaid D; Thibodeau SN; Couch FJ
    Cancer Res; 2000 Mar; 60(5):1371-5. PubMed ID: 10728701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of heterozygosity at the BRCA2 locus detected by multiplex ligation-dependent probe amplification is common in prostate cancers from men with a germline BRCA2 mutation.
    Willems AJ; Dawson SJ; Samaratunga H; De Luca A; Antill YC; Hopper JL; Thorne HJ;
    Clin Cancer Res; 2008 May; 14(10):2953-61. PubMed ID: 18445692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid progression of prostate cancer in men with a BRCA2 mutation.
    Narod SA; Neuhausen S; Vichodez G; Armel S; Lynch HT; Ghadirian P; Cummings S; Olopade O; Stoppa-Lyonnet D; Couch F; Wagner T; Warner E; Foulkes WD; Saal H; Weitzel J; Tulman A; Poll A; Nam R; Sun P; ; Danquah J; Domchek S; Tung N; Ainsworth P; Horsman D; Kim-Sing C; Maugard C; Eisen A; Daly M; McKinnon W; Wood M; Isaacs C; Gilchrist D; Karlan B; Nedelcu R; Meschino W; Garber J; Pasini B; Manoukian S; Bellati C
    Br J Cancer; 2008 Jul; 99(2):371-4. PubMed ID: 18577985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations.
    Gallardo M; Silva A; Rubio L; Alvarez C; Torrealba C; Salinas M; Tapia T; Faundez P; Palma L; Riccio ME; Paredes H; Rodriguez M; Cruz A; Rousseau C; King MC; Camus M; Alvarez M; Carvallo P
    Breast Cancer Res Treat; 2006 Jan; 95(1):81-7. PubMed ID: 16261400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer: What is the real IMPACT of BRCA1/BRCA2 mutation?
    Clyne M
    Nat Rev Urol; 2014 Mar; 11(3):124. PubMed ID: 24492431
    [No Abstract]   [Full Text] [Related]  

  • 13. Twenty-three novel BRCA1 and BRCA2 sequence alterations in breast and/or ovarian cancer families in Southern Germany.
    Meyer P; Voigtlaender T; Bartram CR; Klaes R
    Hum Mutat; 2003 Sep; 22(3):259. PubMed ID: 12938098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with prostate cancer and BRCA2 mutations need urgent treatment.
    Torjesen I
    BMJ; 2013 Apr; 346():f2223. PubMed ID: 23571745
    [No Abstract]   [Full Text] [Related]  

  • 15. Differentiating pathogenic mutations from polymorphic alterations in the splice sites of BRCA1 and BRCA2.
    Claes K; Poppe B; Machackova E; Coene I; Foretova L; De Paepe A; Messiaen L
    Genes Chromosomes Cancer; 2003 Jul; 37(3):314-20. PubMed ID: 12759930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature.
    Liede A; Karlan BY; Narod SA
    J Clin Oncol; 2004 Feb; 22(4):735-42. PubMed ID: 14966099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate-cancer screening targets men with BRCA mutations.
    Bonn D
    Lancet Oncol; 2002 Dec; 3(12):714. PubMed ID: 12473505
    [No Abstract]   [Full Text] [Related]  

  • 18. The clinical impact of genetic susceptibility to prostate cancer.
    Bratt O
    Eur Urol; 2014 Sep; 66(3):500-1. PubMed ID: 24702982
    [No Abstract]   [Full Text] [Related]  

  • 19. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
    Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC
    Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in BRCA2 and taxane resistance in prostate cancer.
    Nientiedt C; Heller M; Endris V; Volckmar AL; Zschäbitz S; Tapia-Laliena MA; Duensing A; Jäger D; Schirmacher P; Sültmann H; Stenzinger A; Hohenfellner M; Grüllich C; Duensing S
    Sci Rep; 2017 Jul; 7(1):4574. PubMed ID: 28676659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.